Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zynrelef vs Adductor Canal Block in Total Knee Arthroplasty
NCT07216586Phase 4Not yet recruiting
- Sponsor
- University of Miami
- Start
- Jan 2027
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine + meloxicam in postoperative pain, sponsored by University of Miami. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
bupivacaine + meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07216586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07216586.